Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

The reason Lilly is worth so much in the market's eyes is down to one drug molecule, tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) and glucagon ... single dose vial of ...

Eli Lilly's Mounjaro enters Indian market, triggering a sharp rise in consultations as obesity rates climb and patients seek more accessible treatment options ...

Orforglipron is the first oral small molecule glucagon-like ... single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program.1 Lilly also reduced the price of the 2.5 ...

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is ...

While the company has not yet launched a product, its VK2735 candidate -- a dual agonist targeting glucagon-like peptide ... 100 million vials and syringe products, and a capacity to produce ...

A Reuters report 1 noted that Hims & Hers began selling various Eli Lilly drugs on their platform—both branded forms of tirzepatide—including Zepbound, a glucagon-like peptide ... Lilly Introduces ...